Formula & Concentration

(emicizumab-kxwh)

Manufacturer

Genentech Inc

Indications

HEMLIBRA is a bispecific factor IXa- and factor X-directed antibody indicated for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients with hemophilia A (congenital factor VIII deficiency) with factor VIII inhibitors. (1)

Product Options

Package Size NDC Presentation
30 mg 50242-0920-01 Vial
60 mg 50242-0921-01 Vial
105 mg 50242-0922-01 Vial
150 mg 50242-0923-01 Vial

Shelf Life & Storage

24 months

Store HEMLIBRA vials in a refrigerator at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. Do not shake. Prior to administration, if needed, unopened vials of HEMLIBRA may be stored out of and then returned to refrigeration. The temperature and total combined time out of refrigeration should not exceed 30°C (86°F) and 7 days (at a temperature below 30°C [86°F]), respectively. Once removed from the vial, discard HEMLIBRA if not used immediately. Discard any unused HEMLIBRA.

Hemlibra

Order Online

or call

800-304-3064

Can't find what you are looking for?

Please call us and we would love to help.

800-304-3064